Work

Early intervention in STAT3 dominant negative disease

Year: 2023

Type: article

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2023.08.044

Authors: Zixiao (Annie) An, Kelli W. Williams, Amanda Urban, Sania Ali, Susan Roy, Christine Lafeer, Jennifer Heimall, Victoria R. Dimitriades, Joie Davis, Heidi H. Kong, Edward W. Cowen, Steven M. Holland, Alexandra F. Freeman

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Medical University of South Carolina, Frederick National Laboratory for Cancer Research, National Institutes of Health Clinical Center, Children's Hospital of Philadelphia, University of California Davis Medical Center, UC Davis Health, University of California, Davis, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,000

Funders: U.S. Department of Health and Human Services, Pfizer, GlaxoSmithKline, Horizon Therapeutics, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G1234541941, G2415337126, G4689185066, G6252953675, G8838525055

OpenAlex ID: W4386484622

FWCI: 0.088

Cites: 10

Cited by: 1

Related to: 10